 |
Pharmaceutical Applications |
|
Firstly, what exactly are Pharmaceuticals? Well, pharmaceutical drugs are chemicals that are not found anywhere in
nature and are therefore not considered an essential or
conditionally essential nutrient in the human diet but are believed to have beneficial health
effects. As such, pharmaceuticals are not part of the inherent bionatural human diet but they can be used to supplement human nutrition so as to promote human health by way of amplifying specifically relevant bodily functions through the means of their ability to mimic natural human related biochemical substances. It is important to note that, technically speaking, any nutraceutical, phytoceutical or zooceutical chemical that is not organically derived is also considered to be a pharmaceutical substance. Furthermore, it is also important to note that it is due these substances being synthetically synthesised that, in many cases and irrespective of our overall new knowledge and capabilities, we are not able to fully control the side effects and other complications and inadequacies relative to these substances. Although many pharmaceuticals will be able to be replaced by our nutritional supplement based treatments, we feel that it is very important for it to be known that, unlike much of the alternative therapies industry, our venture is not one of intentionally trying to rid the world of pharmaceutical drugs nor pharmaceutical companies – or, for that matter, any other biotechnology related entities! We have a strong belief in the need for pharmaceutical products and other biotechnologies, and, as such, we are merely striving to try to serve the concerns of the industry and it's products whilst at the same time serving the concerns of consumers. Our aim is to produce products and services that will better serve, as a whole and in a highly productive and positive manner, both the biotechnology industry and the general health needs of the human race. As such, not only are we striving to not make any current products and services redundant or obsolete but many of them will in fact not become entirely redundant or obsolete, if even redundant or obsolete at all. Wherever possible, what we are merely seeking to do is actually improve upon as many current technologies that we possibly can so as to not only better serve the companies that own these technologies but to also better serve the medical needs of the human race. For example, one highly noted and accepted shortcoming in the use of many pharmaceuticals is that they result in nutritional deficiencies (due to various reasons – this is commonly referred to as Pharmaceutical-Induced Nutritional Deficiencies). This not only lends to specific nutritional deficiencies occurring from the use of pharmaceuticals but also to the unavailability of substrates and/or cofactors for the drugs to influence and/or to be influenced upon, thus reducing both the effectiveness and the longevity of the drugs themselves and/or the metabolites that they help produce and/or reduce. Combining specific nutritional supplements with specific drugs coupled with our new metabolic networking, deliver system and overall general findings we have discovered that major improvements to already existing treatments can be achieved (and this will be especially useful for circumstances requiring an 'extra edge' and/or an extra boost and/or a reduction in ill-effects). Our initial investigations into the combination of specific nutraceuticals with specific pharmaceuticals in order to prevent the relevant deficiencies and other related complications and inadequacies that can occur from the use of pharmaceuticals has thus far demonstrated significant potentiation and longevity of such treatments as well as substantially reducing any relevant side effects and toxicity rates. It should also be noted that nutraceutical products are starting to be marketed by various companies based on the premise that they will correct various Pharmaceutical-Induced Nutritional Deficiencies. However, these products – like that of all other current nutraceutical based products – will not have any major benefits to consumers due to the fact that they are not designed to cater for the metabolic networking requirements, deliver system requirements and overall general findings we have discovered. Other examples, in general, of where pharmaceuticals will still play a vital role include:
The fact of the matter is that, by incorporating our new capabilities, the pharmaceuticals industry stands to make more money than ever before and with far less controversy over side effects, deaths and so on – all of which are of great concern to the industry at present and only getting worse! In fact, it is both important and interesting to note that pharmaceuticals drugs are now the leading cause of death in developed countries! Yes, that's right, more people die from using pharmaceuticals than what do from cancer, heart disease, diabetes and so on. For those who do not already know this, most pharmaceuticals are in fact just either full or partial replicas of nutritional substances and other substances found in our bodies. And, the only reason that most pharmaceutical substances currently work much better than nutraceutical substances is because they are generally prescribed in sub-lethal dosages that forcibly push the body to do what is desired by taking them! What's more, the altered replicas are usually intentionally designed to work with much more potency than that of their nutritional or endogenous equivalents. This is not only done so as to make highly potent substances that will more readily force the body to perform the intended purposes, and therefore increase the success rates, but also to cut down on production, packaging and distribution costs. It is for all of these reasons that pharmaceuticals substances not only work much better than nutritional supplements at performing the same intended tasks but also why they have so many side effects and are so potentially lethal. Having said this, and unfortunately, many nutraceutical, phytoceutical and zooceutical companies are also now taking the same approach and therefore formulating their products at dangerous sub-lethal dosages in order to try to make their products work better. As such, millions of people worldwide are hospitalised each year due to due to complications arising from overdoses of these products! However, with our new capabilities not only can we make all types of products (pharmaceutical, nutraceutical, phytoceutical and zooceutical) far more safer and effective but we can also make them far more efficient. What this means is that, in many instances, far lower dosages can be taken yet with the same or even better therapeutic effects! What's more, where the diagnosed need is ascertained, dosage rates can usually be increased substantially past currently prescribed rates yet without any toxicity occurring. Furthermore, due to our overall new knowledge not only can many new drugs be developed but many drugs that did not make it to market due to their side effects or other issues will be able to be resurrected, perfected and subsequently incorporated into treatment methods (either as isolated methods or in synergism with other drugs and/or nutritional supplements and/or phytoceuticals and/or zooceuticals, depending on each individual case). Furthermore to all this, and as a subsequence, a small number of companion and synergistic drugs will also be able to be either developed or perfected to work systematically with almost every drug that is currently already on the market. A New Era In Pharmaceuticals Will Be ForgedIt is also important to note that with the advancements that will surely eventuate in pharmaceutical based gene expression amplification technologies – due, in most part, to our overall new and ongoing discoveries – and especially in relation to cellular reconstruction capabilities, the need for profoundly evolved nutraceutical capabilities will be of major intrinsic value to the success of these technologies. This is especially true considering that these technologies will put a major strain on the relevant biochemical workings involved and, subsequently, also on any nutrients involved (even far more so than is currently relevant with the use of pharmaceuticals and other general biotechnology practices). Unfortunately, it is not possible to directly utilise nutraceuticals and/or phytoceuticals and/or zooceuticals to amplify gene expressions for use with such things as large scale cellular reconstruction. As such, the only way that these kinds of technologies will be able to be properly and fully developed is via the use of pharmaceutical drugs that will be able to activate large and numerous sets of growth related genes. So, although many current pharmaceutical drugs will be replaced by our nutritional supplement based treatments, the industry will continue to thrive and survive due to being able to forge a whole new era of new gene expression amplification related classes of drugs. At the end of the day, it is important to note that all we are truly striving to achieve is that of serving both the industry and consumers in a manner that will help to provide for far more highly advanced and superior treatments and that are also far more safer and highly effective! For more information concerning our pharmaceuticals and other development capabilities, please refer to our R & D Applications. |
|
| .......................................... | |
| Members Area | |
| Retrieve Password | |
| Menu | |
 |
Introduction |
|
|
Our Newly Discovered Metabolic Networks |
|
|
Our Metabolic Amplification Platform Technology |
|
|
Nutraceutical Applications |
|
|
Pharmaceutical Applications |
|
|
Phytoceutical Applications |
|
|
Zooceutical Applications |
|
|
R & D Applications |
|
|
Diagnostic Applications |
|
|
Our Medical Treatments |
|
|
Advanced Hydrocolloids |
|
|
Partnering With Us |
|
|
Technology Pipeline |